Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Pose

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Hepatology (Baltimore, Md.)|March 5, 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortalityJordi Gratacós-Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, et al.
JHEP Reports : Innovation in Hepatology|September 13, 2023
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver diseaseCelia Martínez-Sánchez, Octavi Bassegoda, Hongping Deng, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2026
RECOMPENSATION FOLLOWING ALCOHOL-RELATED HEPATITIS IS ASSOCIATED WITH INCREASED SURVIVAL: RESULTS FROM A MULTICENTER STUDYJordi Gratacós-Ginès, Pilar Ruz-Zafra, Queralt Herms, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Lancet (London, England)|August 12, 2023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort studyMiquel Serra-Burriel, Adrià Juanola, Feliu Serra-Burriel, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Hepatology (Baltimore, Md.)|March 5, 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortalityJordi Gratacós-Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, et al.
JHEP Reports : Innovation in Hepatology|September 13, 2023
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver diseaseCelia Martínez-Sánchez, Octavi Bassegoda, Hongping Deng, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2026
RECOMPENSATION FOLLOWING ALCOHOL-RELATED HEPATITIS IS ASSOCIATED WITH INCREASED SURVIVAL: RESULTS FROM A MULTICENTER STUDYJordi Gratacós-Ginès, Pilar Ruz-Zafra, Queralt Herms, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Lancet (London, England)|August 12, 2023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort studyMiquel Serra-Burriel, Adrià Juanola, Feliu Serra-Burriel, et al.
Pageof 10